How Much of the Proteome Do We See with Discovery-Based Proteomics Methods and How Much Do We Need to See?
Journal:
Current Proteomics
Volume:
1
Page:
3-12
Author(s):
Scott D. Patterson
Advances in Neuroimaging for HIV-1 Associated Neurological Dysfunction: Clues to the Diagnosis, Pathogenesis and Therapeutic Monitoring
Journal:
Current HIV Research
Volume:
2
Page:
61-78
Author(s):
Michael D. Boska, R. Lee Mosley, Mehmood Nawab, Jay A. Nelson, Marina Zelivyanskaya, Larisa Poluektova, Mariano Ubertia, Huanyu Dou, Travis B. Lewis and Howard E. Gendelman
Subject index to volume 1
Journal:
Current HIV Research
Volume:
2
Page:
95-98
Author(s):
Bentham Science Publishers
Identification and Characterization of the Binding Sites of P-Glycoprotein for Multidrug Resistance-Related Drugs and Modulators
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
1-17
Author(s):
Ahmad R. Safa
Multidrug Resistance in Cancer Chemotherapy and Xenobiotic Protection Mediated by the Half ATP-Binding Cassette Transporter ABCG2
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
31-42
Author(s):
B. Han and J.- T. Zhang
Structure of Multidrug-Resistance Proteins of the ATP-Binding Cassette (ABC) Superfamily
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
53-62
Author(s):
Guillermo A. Altenberg
Biosafety of Onco-Retroviral Vectors
Journal:
Current Gene Therapy
Volume:
3
Page:
501-515
Author(s):
Thierry VandenDriessche, Desire Collen and Marinee K.L. Chuah
Risk Assessment of the Use of Autonomous Parvovirus-Based Vectors
Journal:
Current Gene Therapy
Volume:
3
Page:
567-582
Author(s):
Francis Dupont
Phosphonomethoxyalkyl Analogs of Nucleotides
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2567-2592
Author(s):
Antonin Holy
Anticancer Antifolates: Current Status and Future Directions
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2593-2613
Author(s):
John J. McGuire